Profiling Laboratory Biomarkers Associated with COVID‐19 Disease Progression: A Single‐Center Experience

M Khan, N Shah, H Mushtaq… - International Journal of …, 2021 - Wiley Online Library
Background. There is clinical importance to investigate the disease progression through
potential biomarkers of SARS‐CoV‐2 infection. In the present study, we aim to evaluate the …

Differences in inflammatory markers between coronavirus disease 2019 and sepsis in hospitalised patients.

LO NE, G Rodríguez, ID Reyes, RR KM… - … and Global Health, 2022 - europepmc.org
Background Inflammatory markers are pivotal for the diagnosis of coronavirus disease 2019
(COVID-19) and sepsis. This study compared markers between hospitalised patients with …

Potential Predictors of Poor Prognosis among Severe COVID‐19 Patients: A Single‐Center Study

MM Ghaith, MA Albanghali, AF Aldairi… - Canadian Journal of …, 2021 - Wiley Online Library
Background. Timely detection of the progression of the highly contagious coronavirus
disease (COVID‐19) is of utmost importance for management and intervention for patients in …

[HTML][HTML] Utility of ferritin, procalcitonin, and C-reactive protein in severe patients with 2019 novel coronavirus disease

B Zhou, J She, Y Wang, X Ma - 2020 - europepmc.org
Objectives: It is of clinical significance to evaluate the disease severity and investigate
possible biomarkers of 2019 Novel coronavirus disease (COVID-19). In this study, we aim to …

[PDF][PDF] Assessment of diagnostic and prognostic laboratory biomarkers in severe COVID-19 patients admitted to intensive care unit

M Fawzy, S Ahmed, S Abdelhady - Egypt J. Immunol, 2023 - ejimmunology.org
Abstract Coronavirus disease (COVID-19) is a global pandemic. In the first two years of the
pandemic, nearly 15 million people died worldwide. Accurate and rapid laboratory diagnosis …

COVID-19 infections and inflammatory markers in patients hospitalized during the first year of the pandemic

P Kalaiselvan, P Yingchoncharoen… - Journal of Primary …, 2023 - journals.sagepub.com
Background: The clinical presentations in patients with SARS-CoV-2 (COVID-19) infections
range from asymptomatic upper respiratory infections to acute respiratory failure with …

[HTML][HTML] Inflammatory markers and COVID-19 disease progression

SK Sidhwani, T Mirza, A Khatoon, F Shaikh… - Journal of Infection and …, 2023 - Elsevier
Background The COVID-19 pandemic has resulted in a global humanitarian crisis. Despite
ongoing research, transmission risks and many disease characteristics remained unclear …

[HTML][HTML] A biological profile for diagnosis and outcome of COVID-19 patients

M Khourssaji, V Chapelle, A Evenepoel… - Clinical Chemistry and …, 2020 - degruyter.com
Objectives As severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic is
increasing its victims on a global scale with recurring outbreaks, it remains of outmost …

The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis

E Kazemi, R Soldoozi Nejat, F Ashkan… - Annals of clinical …, 2021 - Springer
Background Abnormal laboratory findings are common in patients infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this systematic review was to …

Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID‐19 on Admission

M García-Gasalla, JM Ferrer… - Canadian Journal of …, 2021 - Wiley Online Library
Background. Early identification of COVID‐19 patients at risk of critical illness is a
challenging endeavor for clinicians. We aimed to establish immunological, virological, and …